| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |



* From the Departments of Anaesthesia,
Surgery,
Community Health and Epidemiology, and
Medicine (Division of Cardiology), Queens University, 76 Stuart St., K7L 2V7 Canada.
Address correspondence to: Dr. M.J. Ali, Department of Anesthesia, The Toronto Hospital, 200 Elizabeth Street, Toronto, Ontario, M5G 2C4 Canada. Phone: 416-340-3242; Fax: 416-340-3698; E-mail: mja{at}post.queensu.ca
| Abstract |
|---|
|
|
|---|
Methods: Retrospective review of 119 cardiology and anesthesia consultations over 15 mo, ending March 31, 1998. Patients were classified into their respective medical clinical predictor and surgical risk groups, as outlined in ACC-AHA guidelines. Associations between the medical predictor and surgical risk scores and adverse cardiac outcomes were quantified via multiple logistic regression analysis. Two outcomes were employed. Outcome 1, included: myocardial infarction/ischemia; angina; congestive heart failure, arrhythmia or death. Outcome 2 expanded the definition to include "cancellation of surgery due to cardiac risk" as a negative cardiac outcome.
Results: Diabetes, Canadian Cardiovascular Class (CCS) 111 or 1V angina, and MI within six months before surgery were strongly associated with the two cardiac outcomes. For outcome 1 and 2, medical predictors and surgical risks, considered simultaneously, performed with a sensitivity of 93% and specificity of 46-51%. When considered separately, major clinical medical predictors had a sensitivity of 87-89%, while surgical risks showed a specificity of 89% in predicting the two outcomes.
Conclusion: Medical predictors in ACC-AHA classification scheme were highly sensitive whereas surgical risks were more specific in predicting adverse post-operative cardiac events. Prospective study is needed to confirm these observations.
| Introduction |
|---|
|
|
|---|
Recently, the American College of Cardiology - American Heart Association (ACC-AHA) published guidelines and an associated algorithm for the preoperative cardiovascular evaluation of non-cardiac surgical patients.6 The purpose of these tools is to rationalize testing and to prevent unnecessary interventions in surgical patients. The ability of the guidelines to predict adverse cardiac events has not been tested empirically within a variety of surgical patient populations. Despite this, the ACC-AHA guidelines may become the standard approach used in clinical practice.
We had the opportunity to apply the ACC-AHA guidelines to a cohort consisting of patients undergoing non-cardiac surgery, who were referred to cardiology and/or anesthesia departments for assessment prior to surgery. The cohort was studied with the following objectives: 1) to describe the pre-operative clinical profile of these patients; 2) to determine what proportion of patients were treated in a manner consistent with the ACC-AHA guidelines; 3) to assess quantitatively the risks for negative seven day, postoperative cardiac events associated with the different classes of patients indicated by the guidelines, while simultaneously controlling for other factors; 4) to determine which aspect of the guidelines, clinical (medical) predictor or surgical risk scores, was a better predictor of seven day cardiac outcomes.
| Methods |
|---|
|
|
|---|
Medical records of all patients (n=119) referred to cardiology and/or anesthesia services for preoperative consultation for non-cardiac surgery were reviewed retrospectively for a 15 mo period ending March 31, 1998. Most of these patients required elective or urgent surgery for a variety of conditions. Urgent surgery commonly involved repair of hip fractures, extremity amputations, and progressive limb ischemia requiring revascularization. Elective surgery in adults encompassed all systems except organ transplants. Patients with acute, life-threatening surgical emergencies who went directly to the operating room without cardiology consultation were excluded. Three patients were admitted more than once for separate surgical procedures during the course of the study. These were considered as independent events for the purposes of this study.
Classification according to the ACC-AHA guidelines
Table I
provides a list of both the clinical and surgical characteristics that were considered during the application of the guidelines. Assessment of these patient characteristics allowed their classification according to a medical predictor score and a surgical risk score. Each of these scores has three levels; low, intermediate, and high; indicating the patients' potential risk for adverse cardiac outcome following surgery. The guidelines also provide investigation and management pathways associated with the various levels of risk (Figure
). All 119 patients were classified according to the two scores.
|
|
Consistency of patient management with the ACA-AHA guidelines
Through medical chart review, all patients in the study cohort were evaluated with respect to their medical management, and a determination was made to see if the latter was consistent with recommended investigative and therapeutic pathways6 (Figure
). Steps not followed in the ACA-AHA guidelines and their associated algorithm were documented.
Assessment of other patient characteristics
Data were also collected by medical chart review on previously established risk factors for cardiac events, which included patient demographics and co-morbid disease (diabetes, renal dysfunction, cerebrovascular, peripheral vascular, and chronic obstructive pulmonary disease).7,10,1318 The type of anesthesia employed during surgery, if applicable, was also recorded. These patients were followed clinically for seven days after surgery.
Seven - Day cardiac outcome
Negative, postoperative cardiac events were defined operationally as those that occurred during the seven days after surgery. They included diagnoses of at least one of: a) myocardial infarction (MI); b) ischemia; c) angina; d) congestive heart failure (CHF); e) arrhythmia; f) death. Cancellation of surgery due to perceived cardiac risk was also documented. Criteria for diagnosis of the cardiac events remained with the consulting service, and we simply recorded their observations during our retrospective chart review. However, a cardiologist involved in the study, used serial electrocardiograms, rhythm strips, cardiac enzymes and chest X-rays to confirm these diagnoses. If patients were discharged from the hospital earlier than seven days after surgery, medical record data base of KGH and HDH were scanned to pick up subsequent admissions for cardiac or surgical reasons. This strategy would pick up cardiac events as KGH and HDH are the only major hospital for admission and treatment of acute cardiac problems in the catchment area.
Analysis
Characteristics of the study population were described using univariate statistics. The percentage of patients who were managed according to the ACC-AHA protocol was calculated. Associations between independent variables and negative cardiac outcomes were quantified using logistic regression and chi-square statistics. Two study outcomes were employed in separate analyses. The first defined a negative, seven-day cardiac outcome as any listed in a) through f) above. The second expanded the definition to include cancellation of surgery due to cardiac risk as a negative cardiac outcome. The sensitivity and specificity of the medical predictor and surgical risk scores in predicting negative cardiac outcomes were calculated. This was done for the two scores alone, and then in combination.
The approach to logistic regression modeling went as follows. First, bivariate analyses were used to assess the strength and statistical significance of associations between patient characteristics and the two negative cardiac outcomes. Second, similar analyses were used to describe associations between the 1) ACC-AHA medical predictor score, and 2) ACC-AHA surgical risk score, and the two measures of negative (or poor) cardiac outcomes. Third, multiple logistic regression analyses were used to quantify these associations, while simultaneously controlling for other risk factors identified in bivariate analysis.
| Results |
|---|
|
|
|---|
|
With respect to the medical predictor score, 18 patients classified as "low" risk and 38 as "intermediate" risk were managed based on their activity levels, as suggested by their medical history11,12 and type of surgery4 (Table I
). Patients with an acceptable level of activity, defined as being able to climb a flight of stairs or walk up a hill (4 metabolic equivalent/met by Duke activity status11,12), slated for intermediate or low risk procedure went directly to surgery, while those with limited ability to exercise underwent further cardiac testing and treatment if dictated by the ACC algorithm6 (Figure
). Among patients with a high medical predictor risk score, anesthesia and surgery was delayed in 50 and canceled or modified in 13 patients. Urgent surgery (e.g. hip fracture) was performed after limited investigation and medical optimization of acute conditions such as rhythm disturbance and congestive heart failure, as appropriate. The remaining high-risk patients underwent cardiac testing and treatment.
Ninety-six percent (n=114) of the patients were treated according to the ACC-AHA guidelines, upon retrospective application of the medical predictor score and algorithm.6 In the five cases where the guidelines were not followed, clinicians failed to document the patients' exercise tolerance. No adverse events were observed among these patients. Where indicated, cardiac testing included 2D echocardiogram in 32 patients, coronary angiogram in eight, 24 hr Holter monitoring in six, exercise stress test in four and stress echo in three. Cardiac treatment included introduction or change in cardiac medication including nitrates, calcium antagonists, diuretics or antiarrhythmics. Widespread use of ß blocker was absent despite recent support for their use.19,20
Bivariate analysis
Associations between a variety of patient characteristics and negative seven-day cardiac outcomes are quantified in Table III
. In general, the strength and direction of associations were consistent for the two negative cardiac outcomes employed. Strong associations that approached statistical significance (P < 0.10) were observed for the presence of diabetes, CCS Class III or IV angina, MI prior to surgery, and MI within six months of the scheduled date of surgery.
|
|
|
| Discussion |
|---|
|
|
|---|
Our results were consistent with previous studies, in that recent MI, diabetes, advanced angina, and CHF were all shown to be predictors of a negative outcome following non-cardiac surgery.7,9,13 In addition, we showed that the medical predictor score in the ACC-AHA classification scheme performed extremely well, with a sensitivity of 87% in predicting adverse cardiac events, in a diverse group of surgical patients. The medical predictor score performed much better then the surgical risk score in identifying high-risk patients. This suggests that cardiac conditions that patients bring to the operating room are a more important determinant of adverse outcome than the type of surgery they are about to undergo.
Limitations to the ACC-AHA guidelines and our study must be stressed. For example, the ACC treatment algorithm is broad and permits more than one management pathway in certain circumstances. A patient presenting with stable CCS class 2 - 3 angina, for example, can be correctly managed with coronary angiography and revascularization (coronary angioplasty or coronary surgery), or be optimized with cardiac medication prior to non-cardiac surgery.27,28 This allowed clinicians with different management strategies to remain in compliance with the guidelines and algorithm. Objective outcome comparison of conservative vs invasive approach with in the ACC guidelines was not possible in this study as only a few patients underwent revascularization.
Second, the guidelines are not clear on how long to delay surgery after introducing cardiac medication to optimize patient's preoperative cardiac condition. In addition, they do not indicate how to assess perioperative risk reduction benefit once a drug is started. In our setting, these medications were often started the evening prior to surgery.
Third, a large portion of the guidelines is based on observational or retrospective studies, as well as knowledge of cardiovascular disease management in non-operative settings.6 Similarly, this study was a retrospective evaluation of 119 surgical patients selected on the basis of being referred for a cardiology and anesthesia consultation. Therefore, caution must be used in extrapolating the estimate of the cardiac events from this retrospective cohort to an unselected surgical population since the prevalence and outcome may vary as shown recently in another condition.29 The guidelines have yet to be clinically evaluated prospectively in a large population, and in operative settings.
We used traditional cardiac outcomes such as angina, congestive heart failure, arrhythmia, myocardial infarction and ischemic ST-T changes. In addition, we felt that cancellation of surgery for cardiac reasons deprived patients of the potential for cure of their surgical disease, and therefore considered it as a novel but clinically relevant negative outcome variable. For example, one patient in our study was denied curative lobectomy30 for carcinoma of the lung due to cardiac risk of surgery. However, the results of the analysis were consistent with those obtained when surgery cancellation was not considered as a negative study outcome.
Alternative techniques to treat diseases traditionally requiring stressful surgery may offer attractive options to reduce cardiac risk in future.31 This was possible in only three patients in our study. Two underwent percutaneous cholecystostomy and endoscopic gallstone removal while one under went bronchial embolization instead of thoracotomy. There were no adverse cardiac events in these patients.
Some authors have suggested that non-cardiac morbid events such as respiratory complications, renal failure, strokes, and bleeding requiring major transfusion exceed perioperative cardiac events.3234 We did not observe that to be true. In our study, only one patient succumbed to postoperative surgical bleeding and low cardiac output state. However, we did not specifically document postoperative serum creatinine, chest x-ray findings or arterial blood gases in this study.
Anesthetic technique was not a determinant of cardiac outcome in this study. Again, this is consistent with earlier findings.35,36 The effect of postoperative analgesic regimen on cardiac outcome was not investigated in this study.
This study included a diverse group of patients likely to be seen in a busy surgical, anesthetic and cardiology practice. The patient mix involved a variety of ischemic, valvular, arrhythmic and other cardiac conditions encountered frequently in the operating room. We believe this validation study to be unique in that evaluation of the ACC-AHA guidelines in a cohort such as this has not been reported.
The study confirms that the ACC-AHA guidelines and risk classification of surgical patients were predictive of postoperative adverse cardiac events. It suggests that the clinical (medical) predictor score was highly sensitive in detecting patients at high risk for negative cardiac outcome, while the surgical risk score was less sensitive and more specific. Prospective study with a larger group of surgical patients recruited from a preoperative assessment clinic is warranted to confirm these observations.
| Acknowledgments |
|---|
Accepted for publication September 6, 1999.
| References |
|---|
|
|
|---|
2 Harrison DC. Cost containment in medicine: why cardiology? Am J Cardiol 1985; 56: 10C5.[Medline]
3 Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990; 72: 15384.[Medline]
4 McPhail N, Calvin JE, Shariatmadar A, Barber GG, Scobie TK. The use of preoperative exercise testing to predict cardiac complications after arterial reconstruction. J Vasc Surg 1988; 7: 608.[Medline]
5 Lubitz J, Deacon R. The rise in incidence of hospitalizations for the aged, 1967 to 1979. Health Care Financing Review 1982; 3: 2140.[Medline]
6 ACC/AHA Task Force Report. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology /American Heart Association Task Force on Practice Guidelines. JACC 1996; 27: 91048.[Medline]
7 Detsky AS, Abrams HB, McLaughlin JR, et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986; 1: 2119.[Medline]
8 Steen PA, Tinker JH, Tarhan S. Myocardial reinfarction after anesthesia and surgery. JAMA 1978; 239: 256670.[Abstract]
9 Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989; 110: 85966.
10 Vanzetto G, Machecourt J, Blendea D, et al. Additive value of thallium single-photon emission computed tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery. Am J Cardiol 1996; 77: 1438.[Medline]
11 Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self -administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989; 64: 6514.[Medline]
12 Nelson CL, Herndon JE, Mark DB, Pryor DB, Califf RM, Hlatky MA. Relation of clinical and angiographic factors to functional capacity as measured by Duke Activity Status Index. Am J Cardiol 1991; 68: 9735.[Medline]
13 Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297: 84550.[Abstract]
14 Lundqvist BW, Bergström R, Enghoff E, Eriksson I, Modig J, Ström G. Cardiac risk in abdominal aortic surgery. Acta Chir Scand 1989; 155: 3218.[Medline]
15 Steyerberg EW, Kievit J, de Mol Van Otterloo JCA, van Bockel JH, Eijkemans MJC, Habbema JDF. Perioperative mortality of elective abdominal aortic aneurysm surgery. A clinical prediction rule based on literature and individual patient data. Arch Intern Med 1995; 155: 19982004.[Abstract]
16 Michel LA, Jamart J, Bradpiece HA, Malt RA. Prediction of risk in noncardiac operations after cardiac operations. J Thorac Cardiovasc Surg 1990; 100: 595605.[Abstract]
17 Miller K, Atzenhofer K, Gerber G, Reichel M. Risk prediction in operatively treated fractures of the hip. Clin Orthop 1993; 293: 14852.
18 Poldermans D, Arnese M, Fioretti PM, et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol 1995; 26: 64853.[Abstract]
19
Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996; 335: 171320.
20 Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology 1998; 88: 717.[Medline]
21 Fleisher LA. Preoperative assessment of patient with cardiovascular disease. ASA Refresher Course Lectures 1997; 144: 17.
22 Jeffrey CC, Kunsman J, Cullen DJ, Brewster DC. A prospective evaluation of cardiac risk index. Anesthesiology 1983; 58: 4624.[Medline]
23
Fleisher LA, Eagle KA. Screening for cardiac disease in patients having noncardiac surgery. Ann Intern Med 1996; 124: 76772.
24 Zeldin RA. Assessing cardiac risk in patient who undergo noncardiac surgical procedures. Can J Surg 1984; 27: 4024.[Medline]
25
Larson SF, Olesen KH, Jacobsen E, et al. Prediction of cardiac risk in non-cardiac surgery. Eur Heart J 1987; 8: 17985.
26
Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med 1995; 333: 17506.
27 Mason JJ, Owens DK, Harris RA, Cooke JP, Hlatky MA. The role of coronary angiography and coronary revascularization before noncardiac vascular surgery. JAMA 1995; 273: 191925.[Abstract]
28 Foster ED, Davis KB, Carpenter JA, Abele S, Fray D. Risk of noncardiac operation in patients with defined coronary disease: the Coronary Artery Surgery Study (CASS) registry experience. Ann Thorac Surg 1986; 41: 4250.[Abstract]
29
Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999; 341: 17.
30 Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96: 4407.[Abstract]
31 Brewster DC, Geller SC, Kaufman JA, et al. Initial experience with endovascular aneurysm repair: comparison of early results with outcome of conventional open repair. J Vasc Surg 1998; 27: 9921005.[Medline]
32 Khuri SF, Daley J, Henderson W, et al. The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care. J Am Coll Surg 1995; 180: 51931.[Medline]
33 Des Prez RD, Friesinger GC, Reed GW, et al. A simple accurate model of predicting myocardial infarction after general surgery (Abstract). Circulation 1995; 92: I-744.
34
Palda VA, Detsky AS. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 1997; 127: 31328.
35 Christopherson R, Beattie C, Frank SM, et al. Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology 1993; 79: 42234.[Medline]
36 Baron J-F, Bertrand M, Barré E, et al. Combined epidural and general anesthesia versus general anesthesia for abdominal aortic surgery. Anesthesiology 1991; 75: 6118.[Medline]
This article has been cited by other articles:
![]() |
A. B. Juul, J. Wetterslev, C. Gluud, A. Kofoed-Enevoldsen, G. Jensen, T. Callesen, P. Norgaard, K. Fruergaard, M. Bestle, R. Vedelsdal, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ, June 24, 2006; 332(7556): 1482 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Doering, A. W. McGuire, and D. Rourke Recovering From Cardiac Surgery: What Patients Want You To Know Am. J. Crit. Care., July 1, 2002; 11(4): 333 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P Reginelli and R. M Mills Non-cardiac surgery in the heart failure patient Heart, May 1, 2001; 85(5): 505 - 507. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |